Brief: Scope Fluidics Unit Gets Non-Binding Letter From Astrazeneca Poland
30/07/2019 11:00
July 30 (Reuters) - Scope Fluidics SA SCPP.WA :
* SAYS UNIT BACTEROMIC RECEIVES NON-BINDING LETTER FROM
ASTRAZENECA POLAND
* SAYS IN LETTER ASTRAZENECA POLAND EXPRESSES INTEREST IN
GRANTING
SUPPORT TO UNIT IN BACTEROMIC SYSTEM DEVELOPMENT
Source text for Eikon: ID:nEMbSSX2Ya
Further company coverage: SCPP.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys